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Abstract
Background: Lower limb cellulitis and deep vein thrombosis share clinical features and investigation of patients
with cellulitis for concurrent DVT is common. The prevalence of DVT in this group is uncertain. This study aimed to
determine the prevalence of deep vein thrombosis (DVT) in patients with lower limb cellulitis and to investigate the
utility of applying the Wells algorithm to this patient group.
Methods: Patients admitted with lower limb cellulitis prospectively underwent a likelihood assessment for DVT
using the Wells criteria followed by investigation with D-dimer and ultrasonography of ipsilateral femoral veins as
appropriate. Diagnoses of contralateral DVT or pulmonary embolism during admission were recorded.
Results: 200 patients assessed for DVT. 20% of subjects were high risk by Wells criteria. D-dimer was elevated in 74%
and 79% underwent insonation of the affected leg. Ipsilateral DVT was found in 1 patient (0.5%) and non-ipsilateral VTE
in a further 2 (1%).
Conclusions: Deep vein thrombosis rarely occurs concurrently with lower limb cellulitis. The Wells score substantially
overestimates the likelihood of DVT due to an overlap of clinical signs. Investigation for DVT in patients with cellulitis is
likely to yield few diagnoses and is not warranted in the absence of a hypercoaguable state.
Trial registration: ACTRN: 12610000792022 (https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=320662)
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Background
Cellulitis is a clinical diagnosis based on erythema, swelling
and local tenderness of the skin and subcutaneous tissues
accompanied by fever and malaise [1]. Cellulitis of the
lower limb shares several clinical characteristics with deep
vein thrombosis (DVT) and both have variability of clinical
signs. These factors may lead to diagnostic uncertainty.
This is particularly important in patients with clinically di-
agnosed cellulitis who are slow to respond to antimicro-
bials. A previous retrospective study in our institution
indicated that approximately 15% of patients admitted to
hospital with cellulitis underwent ultrasonography but
the number of DVT detected was very low and only oc-
curred in those with additional risk factors such as pelvic
malignancy or injection drug use [2]. Other investigators
have estimated the prevalence of DVT in patients with cel-
lulitis or erysipelas. This has varied considerably from 1%
to 15% [3-7]. Application of these results to clinical practice
has been limited due to the absence of an assessment of the
clinical likelihood of venous thromboembolism (VTE). The
prevalence of DVT in this group is important because of
the resources required for investigation for deep vein
thrombosis, and treatment with anticoagulation has been
proposed as an adjunct in patients with erysipelas due to
the purported link [8].
There have been several studies outlining the value of
clinical assessment for DVT. Goodacre et al. in a meta-
analysis showed that individual clinical features are of lim-
ited value, but that a combination of variables increases
the diagnostic utility [9]. The Wells score is a widely used
clinical assessment tool using multiple clinical criteria,
which when combined predict the probability of
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DVT [10]. The score ranges from −2 to 9, with a score
of ≥2 designated as high risk. Populations previously stud-
ied for DVT have had prevalence estimated between
10-40%. In these studies the likelihood ratio of a high risk
Wells score is 5.2 and 0.25 for those with low risk Wells
scores [9-12]. In patients with skin and soft tissue infec-
tion there is a significant overlap of clinical signs with
those of DVT, and the Wells score may be invalid if the
prevalence of DVT is much lower in this population
The purpose of this study is to estimate the prevalence
of DVT in patients with cellulitis or erysipelas and to de-
termine the utility of applying the Wells algorithm to
this patient group.
Methods
This study is a prospective cohort study undertaken
at the sole tertiary referral hospital in Christchurch,
New Zealand. The trial was registered with the Australian
New Zealand Clinical Trials Registry (ACTRN: 12-
610000792022) https://www.anzctr.org.au/Trial/Registra-
tion/TrialReview.aspx?id=320662. The study was in
compliance with the Helsinki Declaration and ethical
approval was obtained from the Upper South B (New
Zealand) Regional Ethics Committee (URB/10/02/006).
Patients admitted under the adult internal medical service
with a diagnosis of cellulitis or erysipelas of the lower limb
were recruited within 48 hours of admission and investi-
gated for DVT. Patients gave written informed consent
prior to recruitment. The diagnosis of cellulitis was made
on clinical grounds by an attending physician. Investiga-
tion for DVT was performed by calculation of a pre-test
probability using the Wells score, with a score of ≥2 desig-
nated high risk, and D-Dimer assay (IL D-Dimer HS,
Instrumentation Laboratory, Italy) using 250 ng/ml as the
positive cut-off [9]. Ultrasonography of the leg was
performed if the patient was high risk by the Well’s criteria
or was low risk but had a positive D-dimer [9]. Ultrasonog-
raphy was of the ipsilateral femoral and popliteal vein in-
cluding a phasicity assessment of the common femoral vein
[10]. If the patient was high risk on Wells criteria and had a
positive D-dimer and negative ultrasound of the limb, they
were followed up at 3 months and all subsequent diagnoses
of DVT recorded.
It was calculated that recruitment of 203 patients would
give a margin of error of +/− 3% if the prevalence of DVT
was 5%. Due to logistical limitations, only 1 patient/day
was recruited. When more than 1 case was admitted per
day (range 0–3), the case for enrollment was randomly se-
lected by die roll. Exact Clopper-Pearson 95% binomial
confidence intervals around proportions were calculated
using http://statpages.org/confint.html.
Results
The investigative algorithm is illustrated in Figure 1.
Two hundred and ten cases were approached of whom 9
declined to participate. Of the remaining 201 subjects, 1
failed to complete the protocol. Patient characteristics
are detailed in Table 1. Evaluation of the clinical risk of
DVT by the Wells’ criteria categorized 41 (21%) patients
at high risk and 151 (79%) at low risk of ipsilateral DVT.
The prevalence of individual clinical characteristics is
listed in Table 2.
Prevalence of suggestive clinical features such as leg
swelling and venous tenderness was high and risk factors
for thromboembolism were less common. Of the 77 who
were recently bedridden or recently undergone major sur-
gery, 27 had undergone surgery within 12 weeks and the
remainder had been bedridden due to medical illness.
All patients underwent a D-dimer assay and 148 (74%)
were elevated. 158 (79%) underwent insonation of their
affected leg.
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Figure 1 Flow chart for patients with cellulitis investigated for DVT.
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One of the 200 subjects (0.5%, 95% CI 0.01-2.7%) who
completed the protocol was diagnosed with an ipsilateral
DVT. The prevalence of DVT in the high risk group was
1/41(2.4%; 95% CI 0.6-12.8%) and 0/159 (0%; 95% CI 0.00-
2.3%) in the low risk group, the difference is not significant
using Fisher’s exact test (P=0.2), and with no cases in the
low risk group the odds ratio is not finite. The subject with
a DVT presented with 2 days of erythema of their calf and
thigh and a fever of 39 degrees Celsius. This was preceded
by 1 week of leg swelling. The subject's Wells score was 2,
placing them in the high risk group, and their D-dimer
was 1095ng/ml. Insonation of the affected leg found oc-
clusive thrombus in the femoral vein.
In addition, one patient had a clinically silent contralat-
eral DVT diagnosed when the wrong leg was scanned in
error. One other patient was diagnosed with a symptom-
atic pulmonary embolus during her admission despite no
ultrasonic evidence of DVT bilaterally.
Discussion
This study demonstrates that despite high rates of clinically
compatible signs, DVT prevalence in patients with cellulitis
approximates that found in other studies of unselected hos-
pital inpatients where prevalence of symptomatic venous
thrombosis has been estimated at 0.6-0.8% [13,14]. The
diagnosis in this study of a greater number of incidental
venous thromboembolic events is in keeping with this.
The low prevalence of DVT in patients deemed high
risk by the Wells’ criteria suggests that this evaluation
tool is not suitable to this patient group. The overlap of
clinical signs such as leg swelling reduces the specificity
of this tool and the low prevalence adversely affects the
positive predictive value of a “high risk” assessment. The
very low prevalence of DVT contrasts with those in
whom the Wells score was validated in which DVT was
found in 27% of the high risk group and 4.3% of the low
risk group [9]. All patients included in this study had 2
points deducted from the Wells score, due to the assess-
ment that cellulitis was a more likely explanation for the
clinical signs. If this was not done, the overestimation of
risk would be much higher and the prevalence of DVT in
the high risk group would be 0.6% (95% CI 0.02-3.7%).
In Wells’ study, 2 of 218 patients assessed as low risk
and with a negative D-dimer were diagnosed with VTE
within 3 months. On the basis of this result, it was
asserted that ultrasonography can safely be omitted in this
group [9,15]. The data from this study shows that in pa-
tients with cellulitis, prior to any risk stratification, DVT is
just as unlikely.
The diagnosis of cellulitis was made solely at the dis-
cretion of the treating physician as there are no widely
accepted criteria and cellulitis is diagnosed on clinical
grounds [1]. It is therefore possible that other illnesses
may be misdiagnosed as cellulitis. This uncertainty is an
unavoidable aspect of management of cellulitis. There is
limited application of the results of this study to those
patients at very high risk due to the low number of these
patients included. This primarily includes those with a
Table 1 Patient characteristics
Age (mean/range) 62 years (17–96 years)
Gender Male 110 (55%)
Ethnicity Caucasian 182 (91%), Maori 12(6%) and Pacific People 6 (3%)
Fever (>38 degrees Celsius on admission) 111 (56%)
Pulse (median/range) 90 (55–149)
Blood Pressure (median/range) 131/70 (88-177/50-114)
Extent of cellulitis Below knee 132 (66%), above knee 15 (7.5%), both above and below knee 53 (25.5%)
Skin and soft tissue changes Blistering 34 (17%), associated ulcer 34 (17%), subcutaneous haemorrhage 30 (15%), associated wound
16 (8%), abscess formation 14 (7%)
Severity markers Acute kidney injury 28 (14%),death during admission 8 (4%), bacteraemia 7 (3.5%)
(S. aureus 4, beta haemolytic streptococci 3), Intensive care admission 3 (1.5%)
Co-morbidities Heart disease 88(44%), diabetes 48(29%), chronic respiratory disease 56 (28%), chronic renal
insufficiency 46(23%), central neurological disease or peripheral neurological disease affecting
the lower limbs 34(17%), previous or active cancer 30 (15%), cirrhosis 5 (2.5%).
Anti-coagulant and anti-platelet medication Anti-platelet therapy 70 (35%), and 14 (7%) anti-coagulant therapy 14 (7%).
Table 2 Prevalence of individual Well’s score characteristics
Active cancer 17 (8.5%)
Paralysis, paresis or recent plaster immobilization 12 (6%)
Recently bedridden >3 days/major surgery within 12
weeks
77 (38.5%)
Localized tenderness along the venous system 76 (38%)
Entire swollen leg 98 (49%)
Calf swelling >3 cm compared to that on
asymptomatic side
152 (76%)
Collateral superficial veins 38 (18%)
Previous deep vein thrombosis 34 (17%)
Alternative diagnosis at least as likely as DVT 200 (100%)
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hypercoaguable state, such as those with active malig-
nancy. Anticoagulation will reduce the chance of DVT,
but the small number of patients on anticoagulants
were included as thrombosis can still occur, especially
when anticoagulation is subtherapeutic. A large propor-
tion of patients were taking aspirin but this does not
substantially reduce venous thromboembolism [16]. The
method of insonation of the femoral and popliteal veins
was performed in accordance with current guidelines
but only a single ultrasound was performed in the
assessment of DVT. It is possible that calf DVTs were
missed by this approach and clinical pathways recom-
mend a repeat ultrasound at 5–7 days for those in the
high risk group to ensure propagation of calf DVT into
the femoral veins has not occurred [10]. No patients
were diagnosed with DVT during the 3 months of follow
up, which makes this unlikely to have an important
affect on the estimated prevalence.
Conclusion
In conclusion, DVT is a very uncommon occurrence in
patients with cellulitis and current tools for assessing the
likelihood of DVT overestimate the risk due to an overlap
of clinical signs. Routine investigation for DVT in patients
with cellulitis is likely to yield few diagnoses and is not
warranted in the absence of a hypercoaguable state.
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